No Data
No Data
The latest research results of the Phase I clinical study and Phase I/II clinical study of JSKN003 presented by Kangning Jerry Pharmaceutical-B (09966) at the 2024 ESMO conference.
CSPC Pharmaceutical Group Limited (09966) issued an announcement regarding the late-stage treatment of JSKN003 in Australia...
Alphamab Oncology To Publish Cancer Drug's Phase III Trial Results
Latest progress on the Phase III clinical trial of KN046 for the treatment of advanced squamous NSCLC by Conno Gene Pharmaceutical -B (09966).
Corning Jerritt Pharmaceuticals-B (09966) announced that it has released a notice regarding the Phase III clinical trial study of KN046...
HKEX News: Kunming Jerray Pharmaceuticals-B (09966) is currently down more than 5%, and the mid-year loss has expanded by 12% year-on-year. In May, it announced the failure of the KN046-303 clinical trial.
Kangning Jerry Pharmaceutical-B (09966) is now down more than 5%. As of the time of writing, it has dropped by 5.56% to HKD 2.38, with a turnover of HKD 4.2985 million.
Alphamab Oncology's Loss Widens in H1 as Other Gains Plunge; Shares Jump 7%
Alphamab Oncology Reports 2024 Interim Results and Business Highlights
No Data
No Data